Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
CK Hutchison Unit Launches Arbitration Against Panama Over Port Concessions Ruling 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Boeing Signals Progress on Delayed 777X Program With Planned April First Flight 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
TriCore Reference Laboratories announced today that David G. Grenache, PhD; has been selected as its first Chief Scientific Officer, effective September 2017.
|
|||
In this role, Dr. Grenache will be responsible for oversight of the core lab’s strategic direction and planning, as well as contributing to the leadership of the TriCore Research Institute. Dr. Grenache will function as Scientific Director of TriCore’s core laboratory that performs 10.5 million clinical tests each year. Dr. Grenache will join TriCore’s executive leadership team and report to TriCore’s Chief Medical Officer, Michael Crossey, MD, PhD.
The TriCore executive team is very excited about the new addition to the team. Dr. Crossey said, “I have been fortunate to know Dr. Grenache for many years through the AACC (American Association for Clinical Chemistry) where he has served in multiple capacities. He is widely known as a leading expert in maternal/fetal clinical chemistry issues and one of the best clinical chemists and medical educators I know. I am so pleased to have him join our team at TriCore.”
Khosrow Shotorbani, TriCore’s President, and CEO expressed enthusiasm regarding Dr. Grenache, “New Mexico is gaining a new citizen with true international expertise. I am confident that the addition of Dr. Grenache to our team will better allow TriCore to support our clinical colleagues, both now and in the future, as we reshape the way healthcare is delivered to improve lives in our New Mexico communities.”
Prior to joining TriCore, Dr. Grenache was a clinical professor of pathology at the University of Utah School of Medicine and a Medical Director in the chemistry division at ARUP Laboratories in Salt Lake City, UT. His research interests are focused on reproductive biochemistry and emerging biomarkers of disease.
##
TriCore Reference Laboratories is an independent, not-for-profit clinical reference laboratory founded and headquartered in Albuquerque, NM, co-sponsored by Presbyterian Healthcare Services and University of New Mexico Health Sciences Center. TriCore provides over 1,700 full-service, state-of-the-art laboratory tests to healthcare professionals and their patients. TriCore also provides analytics and research services, supporting healthcare and scientific organizations worldwide. For more information, visit tricore.org.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/25f475b3-d58d-4e37-888c-bae8d0bbb314
Beth Bailey TriCore Reference Laboratories 5059388393 [email protected]
